MMP13 - matrix metallopeptidase 13 Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 493679
MMP13 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_023239043.2 | XP_023094811.2 | collagenase 3 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
collagenase 3 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99590 | Sotatercept | 99.94% | Unkown |
Clinical Phase
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-12170 | Prinomastat | 98.41% | Phase 3 | |
| HY-12170A | Prinomastat hydrochloride | 98.53% | Phase 3 | |
| HY-12270 | T-5224 | Inhibitor | 99.59% | Phase 2 |
| HY-100113 | Buloxibutid | 98.94% | Phase 2 | |
| HY-10398 | CTS-1027 | Inhibitor | 99.24% | Phase 2 |
| HY-112160 | XL-784 free base | Inhibitor | / | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(67)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-110397 | KP-457 | Inhibitor | 99.18% | Unkown |
| HY-P4931 | Mca-KPLGL-Dap(Dnp)-AR-NH2 | 99.30% | Unkown | |
| HY-N1454 | Apigenin-7-glucuronide | Inhibitor | 99.74% | Unkown |
| HY-N1463 | Luteolin 7-O-glucuronide | Inhibitor | 99.98% | Unkown |
| HY-100359 | CL-82198 | Inhibitor | 99.89% | Unkown |
| HY-12875 | BQU57 | Inhibitor | 98.47% | Unkown |
| HY-107394 | UK 356618 | Inhibitor | 98.91% | Unkown |
| HY-108672 | NF157 | Antagonist | 99.13% | Unkown |
| HY-124029 | BI-4394 | Inhibitor | 99.09% | Unkown |
| HY-N2350 | Cynaropicrin | Inhibitor | 99.79% | Unkown |
| HY-N1508 | Ecliptasaponin A | 99.81% | Unkown | |
| HY-122624 | MMP13-IN-2 | Inhibitor | 99.13% | Unkown |
| HY-19820A | NSC45586 sodium | 98.0% | Unkown | |
| HY-125166 | DB04760 | Inhibitor | 99.18% | Unkown |
| HY-116302 | MMP-9-IN-9 | Inhibitor | 99.26% | Unkown |
| HY-100518 | T-26c | Inhibitor | 99.52% | Unkown |
| HY-107639 | UK-370106 | Inhibitor | ≥99.0% | Unkown |
| HY-128026 | MMP-9/MMP-13 Inhibitor I | Inhibitor | 99.68% | Unkown |
| HY-12168 | Tanomastat | Inhibitor | 99.74% | Unkown |
| HY-107428 | PD-166793 | Inhibitor | 99.21% | Unkown |
| HY-117970 | MMPI-1154 | Inhibitor | 99.76% | Unkown |
| HY-12093 | MMP408 | Inhibitor | 99.04% | Unkown |
| HY-110397G | KP-457 (GMP) | Inhibitor | / | Unkown |
| HY-19485 | XL-784 | Inhibitor | 98.25% | Unkown |
| HY-W011085 | CP-471474 | Inhibitor | 99.2% | Unkown |
| HY-114091 | PF-00356231 hydrochloride | Inhibitor | 99.52% | Unkown |
| HY-147745 | MMP2-IN-2 | Inhibitor | 98.80% | Unkown |
| HY-P4905 | Mca-Pro-Leu-Gly-Leu-Glu-Glu-Ala-Dap(Dnp)-NH2 | Inhibitor | 98.02% | Unkown |
| HY-110116 | SD-2590 hydrochloride | Inhibitor | 99.4% | Unkown |
| HY-N2503 | Ginsenoside F4 | 98.54% | Unkown | |
| HY-100113A | Buloxibutid hydrochloride | / | Unkown | |
| HY-100518A | T 26c sodium | Inhibitor | / | Unkown |
| HY-107013 | CP-544439 | Inhibitor | / | Unkown |
| HY-107640 | WAY-170523 | Inhibitor | / | Unkown |
| HY-110046 | CL-82198 hydrochloride | Inhibitor | / | Unkown |
| HY-113621B | Ageladine A dihydrochloride | Inhibitor | / | Unkown |
| HY-114091A | PF-00356231 | Inhibitor | / | Unkown |
| HY-114396 | BR351 | Inhibitor | / | Unkown |
| HY-119138 | R-130823 | Inhibitor | / | Unkown |
| HY-119185 | AZD-6605 | / | Unkown | |
| HY-120505 | ITZ-1 | Inhibitor | / | Unkown |
| HY-12168B | (Rac)-Tanomastat | Inhibitor | / | Unkown |
| HY-12270S | T-5224-d8 | / | Unkown | |
| HY-14237 | SC-77964 | Inhibitor | / | Unkown |
| HY-149377 | MMP13-IN-4 | Inhibitor | / | Unkown |
| HY-149378 | MMP13-IN-5 | Inhibitor | / | Unkown |
| HY-153913 | MMP-9-IN-7 | Inhibitor | / | Unkown |
| HY-154868 | MMP-13-IN-1 | Inhibitor | / | Unkown |
| HY-181698 | MMP13-IN-6 | Inhibitor | / | Unkown |
| HY-P11641 | GCRRGPLGLSLGKRRCG | Substrate | / | Unkown |
| HY-P11800 | GPLGVRG | / | Unkown | |
| HY-P11800A | GPLGVRGC | Modulator | / | Unkown |
| HY-P2414 | MMP-13 Substrate | / | Unkown | |
| HY-P2414A | MMP-13 Substrate TFA | / | Unkown | |
| HY-P3699 | TNO003 | Substrate | / | Unkown |
| HY-RS08525 | MMP13 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-RS08526 | Mmp13 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-RS08527 | Mmp13 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-100113R | Buloxibutid (Standard) | / | Unkown | |
| HY-123438 | WAY-151693 | Inhibitor | / | Unkown |
| HY-129699 | RH01617 | Inhibitor | / | Unkown |
| HY-162902 | ALK5-IN-82 | Inhibitor | / | Unkown |
| HY-164525 | SD-7300 | Inhibitor | / | Unkown |
| HY-43586 | BR351 precursor | Inhibitor | / | Unkown |
| HY-N13208 | Stevia Powder | / | Unkown | |
| HY-P3699A | TNO003 TFA | Substrate | / | Unkown |
| HY-W670700 | 2,5-Dihydroxy-4-methoxyacetophenone | Inhibitor | 98.55% | Unkown |